Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Piroxicam measurement |
Component |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing piroxicam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam poisoning |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Accidental piroxicam poisoning |
Causative agent (attribute) |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Intentional piroxicam poisoning |
Causative agent (attribute) |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
intoxication par le piroxicam d'intention indéterminée |
Causative agent (attribute) |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam adverse reaction |
Causative agent (attribute) |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Allergy to piroxicam |
Causative agent (attribute) |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam overdose |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Accidental piroxicam overdose (disorder) |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Intentional piroxicam overdose |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
surdose de piroxicam d'intention indéterminée |
Causative agent (attribute) |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20mg/1mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20mg melt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 10mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Product containing piroxicam beta cyclodextrin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Adverse reaction caused by piroxicam (disorder) |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Accidental piroxicam poisoning |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Intentional piroxicam poisoning |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam beta cyclodextrin (substance) |
Is a |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Product containing piroxicam in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing piroxicam in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing piroxicam in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Product containing piroxicam in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Allergy to piroxicam |
Causative agent (attribute) |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 10 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam beta cyclodextrin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20mg conventional release orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
|
Piroxicam 20 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 20 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 20 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing only piroxicam in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing only piroxicam in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Piroxicam 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piroxicam (substance) |
Inferred relationship |
Some |
1 |